Swiss Life Sciences Stock News

ABB (SWX:ABBN) has put fresh attention on its stock after unveiling an IE6 hyper efficiency motor for hazardous areas and outlining a $200 million program to expand medium voltage manufacturing across Europe. See our latest analysis for ABB. The recent IE6 motor launch and the $200 million medium voltage expansion have landed against a strong backdrop, with ABB’s share price at CHF81.34 and a 30 day share price return of 9.53%, while the 1 year total shareholder return of 73.45% and 5 year...

Sonova Holding (SWX:SOON) has just reported first half FY 2026 revenue of CHF1.8 billion and basic EPS of CHF3.16, alongside trailing twelve month revenue of CHF3.6 billion and EPS of CHF9.02 that sit against a mixed track record of earnings and margin trends. The company has seen first half revenue move from CHF1.8 billion in FY 2024 to CHF1.8 billion in FY 2025 and CHF1.8 billion in FY 2026, while basic EPS over those same first half periods shifted from CHF5.97 to CHF3.50 and then CHF3.16...

Roche Group (SWX:ROP) and Genentech plan to present new clinical data across nine cancer medicines at the 2026 ASCO Annual Meeting. The program includes breast cancer results that may be important for clinical practice, with a focus on giredestrant, a selective estrogen receptor degrader. Data span both investigational and approved therapies, including antibody drug conjugates, bispecific antibodies, and treatments for several cancer types. The breadth of readouts could influence treatment...

Barry Callebaut (SWX:BARN) has put product development in the spotlight at the 2026 Sweets & Snacks Expo by reshaping its compound range into a new Cacao Coatings & Inclusions category and launching Cacao Max and cocoa free ChoViva. See our latest analysis for Barry Callebaut. Investors have reacted positively to Barry Callebaut’s recent product announcements, with the share price delivering a 1 month share price return of 12.81% even though the 3 year total shareholder return is down 31.70%,...

Amrize AG ( VTX:AMRZ ) shareholders (or potential shareholders) will be happy to see that the CEO & Chairman, Jan...

Today is shaping up negative for Landis+Gyr Group AG ( VTX:LAND ) shareholders, with the analysts delivering a...

Sonova Holding AG has released its full-year results for the period ended March 31, 2026, reporting sales of CHF 3,605.9 million, net income of CHF 430.6 million, and announcing an annual dividend of CHF 4.70 per share payable on June 23, 2026. Despite lower reported net income year-on-year, the company achieved 5.9% sales growth and a 17.3% increase in normalized EBITA in local currencies, primarily driven by its Hearing Instruments segment and supported by business reshaping and the...

As European markets navigate the challenges of geopolitical tensions and inflationary pressures, investors continue to seek stability and growth through dividend stocks. In such a climate, selecting stocks with robust earnings growth and consistent dividend payouts can be an effective strategy for those looking to generate income while potentially mitigating volatility.

ams-OSRAM (SWX:AMS) drew fresh attention after reporting first quarter 2026 results that showed lower sales and a wider net loss, alongside new guidance indicating slightly softer full-year revenue due to divestments and currency effects. See our latest analysis for ams-OSRAM. The Q1 results and softer full year guidance came after a sharp rebound in the stock, with a 30 day share price return of 50.80% and a 90 day share price return of 119.51%. However, the 3 year total shareholder return...

Novartis (SWX:NOVN) is back in focus after new clinical data showed its radioligand therapy Pluvicto, when added to standard treatment, cut the risk of PSA progression by 58% in a specific prostate cancer setting. See our latest analysis for Novartis. Alongside the Pluvicto data and a series of US manufacturing and research expansions, Novartis has seen firm investor interest, with the share price at CHF117.2 and an 8.02% year to date share price return, while the 1 year total shareholder...

Orell Füssli AG ( VTX:OFN ) stock is about to trade ex-dividend in two days. The ex-dividend date is two business days...

Investors may be asking whether Swisscom at CHF676.0 is offering fair value right now, or if the recent momentum has already priced in the opportunity. The stock has returned 1.0% over the past week, 3.9% over the past month, 16.8% year to date, and 27.2% over the last year, which naturally raises questions about how much of its potential is already reflected in the price. Recent attention on Swisscom has focused on its role as a major Swiss telecom operator and how investors view its...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Partners...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

Q1 earnings spark fresh look at Adecco Group stock Adecco Group (SWX:ADEN) just released Q1 2026 results, with organic revenue growth, higher net income and EBITA, and market share gains in the Americas and APAC putting the stock back in focus. See our latest analysis for Adecco Group. Despite the Q1 2026 earnings lift, the share price has fallen 36.36% year to date, contributing to a 33.17% decline in 1 year total shareholder return and signalling fading momentum despite improving...

In early May 2026, Novartis broke ground on a new 46,000 sq. ft radioligand therapy manufacturing facility in Denton, Texas, part of its US$23.00 billion US manufacturing and research expansion and its fifth radioligand therapy site nationwide. This build-out of a coast-to-coast radioligand therapy network highlights how Novartis is tying manufacturing proximity and reliability directly to complex cancer treatment delivery for US patients. We will now explore how this expanded US radioligand...

Landis+Gyr Group (SWX:LAND) has recently drawn attention after its latest financial data showed annual revenue of $1,625.8m and a net loss of $136.1m, prompting investors to reassess the smart metering specialist. See our latest analysis for Landis+Gyr Group. At a share price of CHF47.85, Landis+Gyr Group has seen short term share price momentum pick up, with a 7 day share price return of 6.93%. However, longer term total shareholder returns over 3 and 5 years remain weak and suggest...

Temenos (SWX:TEMN) is back in focus after a cluster of fresh contracts and product launches, including new core banking deals with Habib Bank Limited and Reliance Bank, as well as extended collaborations with First Abu Dhabi Bank and Questrade Financial Group. See our latest analysis for Temenos. The recent stream of banking deals and AI product launches comes against a mixed backdrop. The share price stands at CHF71.45, with a 90 day share price return of 11.29%, but a year to date share...

ABB (SWX:ABBN) has launched what it describes as the world's first IE6 Hyper-Efficiency motor for hazardous areas. The new motor uses rare earth and magnet free SynRM technology and is certified for use in hazardous environments. The product has received both ATEX and IECEx certifications, targeting sectors such as chemicals, oil & gas, and food manufacturing. ABB operates across electrification and automation, supplying equipment and systems that support industrial customers and critical...

Adecco Group (SWX:ADEN) opened 2026 with Q1 revenue of €5.7b and basic EPS of €0.41, setting a clear benchmark for how the year is starting after a steady run of quarterly results. The company has seen revenue move from €5.6b in Q1 2025 to €5.7b in Q1 2026, while basic EPS over that same period went from €0.36 to €0.41. Trailing twelve month EPS of €1.81 provides a broader earnings backdrop. With net income of €69m in the quarter and a net profit margin of 1.3%, the story now is how...

Villars Holding S.A. ( VTX:VILN ) is about to trade ex-dividend in the next 4 days. The ex-dividend date is usually set...

Sunrise Communications (SWX:SUNN) opened 2026 with Q1 revenue of CHF 722.8 million and a loss per share of CHF 0.55, as net income excluding extra items came in at a loss of CHF 40.3 million. Over the past year, revenue has moved in a relatively tight range between CHF 722.1 million and CHF 788.8 million per quarter, while quarterly EPS has fluctuated between a loss of CHF 0.02 and a loss of CHF 2.00. This puts the latest trailing twelve-month EPS at a loss of CHF 2.08. For investors, the key...

Highlight Event and Entertainment (SWX:HLEE) has posted its FY 2025 results, reporting first half revenue of CHF194.9 million and a loss per share of CHF1.20. On a trailing twelve month basis, revenue stands at CHF544.4 million with a loss per share of CHF10.65, reflecting ongoing profitability pressures. Over recent periods, revenue has moved between CHF235.5 million and CHF310.3 million per half year, while basic EPS has ranged from a loss of CHF0.85 to a loss of CHF1.20. This highlights...

Züblin Immobilien Holding (SWX:ZUBN) has reported its FY 2026 results with first half revenue of CHF 4.95 million and basic EPS of CHF 1.31, while trailing 12 month figures show revenue of CHF 9.84 million and basic EPS of CHF 2.27, both shaped by a CHF 3.1 million one off gain in the period. Over recent periods, revenue has moved from CHF 4.37 million in the first half of FY 2025 to CHF 4.80 million in the second half and then CHF 4.95 million in the first half of FY 2026. EPS shifted from...